Skip NavigationSkip to Content

Differential Effects of the Absence of Interferon-Gamma and Il-4 in Acute Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice

  1. Author:
    Murphy, W. J.
    Welniak, L. A.
    Taub, D. D.
    Wiltrout, R. H.
    Taylor, P. A.
    Vallera, D. A.
    Kopf, M.
    Young, H.
    Longo, D. L.
    Blazar, B. R.
  2. Author Address

    Murphy WJ NCI FREDERICK CANC RES & DEV CTR SAIC FREDERICK BLDG 567 ROOM 210 FREDERICK, MD 21702 USA NCI FREDERICK CANC RES & DEV CTR EXPT IMMUNOL LAB DIV BASIC SCI FREDERICK, MD 21702 USA BASEL INST IMMUNOL CH-4005 BASEL SWITZERLAND NIA NIH BALTIMORE, MD 21224 USA UNIV MINNESOTA DEPT PEDIAT DIV BONE MARROW TRANSPLANTAT MINNEAPOLIS, MN 55455 USA UNIV MINNESOTA DEPT THERAPEUT RADIOL MINNEAPOLIS, MN 55455 USA UNIV MINNESOTA CTR CANC MINNEAPOLIS, MN 55455 USA
    1. Year: 1998
  1. Journal: Journal of Clinical Investigation
    1. 102
    2. 9
    3. Pages: 1742-1748
  2. Type of Article: Article
  1. Abstract:

    Graft-versus-host disease (GVHD), in which immunocompetent donor cells attack the host, remains a major cause of morbidity after allogeneic bone marrow transplantation (BMT), To understand the role of cytokines in the pathobiology of GVHD, we used cytokine knockout (KO) mice as a source of donor T cells. Two different MHC-disparate strain combinations were examined: BALB/c (H2(d)) donors into lethally irradiated CS7BL/6 (H2(b)) recipients or C57BL/6 (H2(b)) donors into B10.BR (H2(k)) recipients. Donor cells were hom mice in which either the interferon-gamma (IFN-gamma) or the IL-4 gene was selectively disrupted to understand the role of these cytokines in acute GVHD. In both strain combinations the same pattern was noted with regard to GVHD onset and morbidity. All mice exhibited the classic signs of acute GVHD: weight loss with skin, gut, and liver pathology resulting in morbidity and mortality. Surprisingly, donor cells obtained from mice lacking IFN-gamma gave rise to accelerated morbidity from GVHD when compared with cells from wild-type control donors. Similar results were obtained using normal donors when neutralizing antibodies to TFN-gamma were administered immediately after the BMT. These results suggest that IFN-gamma plays a role in protection from acute GVHD, In marked contrast, cells obtained from IL-4 KO mice resulted in protection from GVHD compared with control donors. Splenocytes from IFN KO mice stimulated with a mitogen proliferated to a significantly greater extent and produced more IL-2 compared with splenocytes obtained from IL-4 KO or control mice. Additionally, there was increased IL-2 production in the spleens of mice undergoing GVHD using IFN-gamma KO donors. [References: 32]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel